Artemisinin
The new boom in malaria
World Malaria Day, 25 April - The biggest threat is the rise of drug-resistant parasites due to fake and sub-standard medicines. As with other drugs before, this resistance is emerging all along the Mekong, from Cambodia to Myanmar, where the wonder-drug artemisinin is already failing: this threatens malaria victims everywhere.
The new boom in malaria
IPN Opinion article
The outlook for malaria remains poor because of fake drugs and bad governance
Fake drugs kill over 700,000 people every year - new report
IPN Press release
A new IPN study reveals the shocking burden of fake medicines in less developed countries.
What's wrong in the Mekong?
IPN Opinion article
Resistance to the latest anti-malarial drugs is building up in the Mekong Delta and will threaten much of Asia and Africa: the WHO has just put out a warning that catches up with years of research saying the same thing. Mutation plays a part but so do counterfeits, accounting for a quarter of all medicines in developing countries and a third in Africa.
There's no silver bullet for malaria
IPN Opinion article
Drug resistant malaria portends a health disaster, provoked by widespread substandard drugs. While cheaper drugs may help, this will not solve a problem that is embedded by other factors such as weak trademark laws.
Malaria: Great Idea, Bad Scheme
IPN Opinion article
The great idea is to supply cheap anti-malarials through the private sector in Africa: the trouble is that the scheme is not proven and the Global Fund money could be better deployed in existing and effective anti-malaria campaigns.
